| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1210/ER.14.1.20 |
| P8608 | Fatcat ID | release_yxntq4l3pvatjprzvpxfgdaltq |
| P698 | PubMed publication ID | 8491152 |
| P2093 | author name string | Blackman MR | |
| Harman SM | |||
| Corpas E | |||
| P433 | issue | 1 | |
| P304 | page(s) | 20-39 | |
| P577 | publication date | 1993-02-01 | |
| P1433 | published in | Endocrine Reviews | Q3054007 |
| P1476 | title | Human growth hormone and human aging | |
| P478 | volume | 14 |
| Q40439010 | 1994 Mack-Forster Award Lecture. Review. Studies on the regulation of hepatic cholesterol metabolism in humans |
| Q51493161 | Age changes the diagnostic accuracy of mean profile and nadir growth hormone levels after oral glucose in postoperative patients with acromegaly. |
| Q90247493 | Age-Related Changes in MicroRNA in the Rat Pituitary and Potential Role in GH Regulation |
| Q78577454 | Age-dependency of insulin-like growth factors, insulin-like growth factor-binding proteins, and acid labile subunit in plasma and wounds of surgical patients |
| Q30625276 | Age-related changes of serum sex hormones, insulin-like growth factor-1 and sex-hormone binding globulin levels in men: cross-sectional data from a healthy male cohort |
| Q73196664 | Age-related variations in the neuroendocrine control, more than impaired receptor sensitivity, cause the reduction in the GH-releasing activity of GHRPs in human aging |
| Q92660543 | Age-specific variations in hematological and biochemical parameters in middle- and large-sized of dogs |
| Q35667556 | Ageing, growth hormone and physical performance |
| Q34442619 | Aging, resistance training, and diabetes prevention |
| Q80148192 | Approach to the evaluation of the GH/IGF-axis in patients with pituitary disease: which test to order |
| Q33594133 | Association between risk factors for vascular dementia and adiponectin |
| Q37593955 | Associations between gender, age and waist circumference. |
| Q34131042 | Associations of insulin and insulin-like growth factors with physical performance in old age in the Boyd Orr and Caerphilly studies |
| Q47327006 | Basal growth hormone concentration increased following a weight loss focused dietary intervention in older overweight and obese women |
| Q91649163 | Beyond the androgen receptor: the role of growth hormone secretagogues in the modern management of body composition in hypogonadal males |
| Q43725575 | Bone metabolism and body composition in Japanese patients with active acromegaly |
| Q34268353 | Bone mineral density in acromegaly: does growth hormone excess protect against osteoporosis? |
| Q33723624 | Can GHRH or GH secretagogues re-initiate pituitary GH pulsatility? |
| Q35898648 | Cardiac aging: from molecular mechanisms to significance in human health and disease |
| Q36309188 | Cardiovascular risk in aging and obesity: is there a role for GH. |
| Q37592856 | Chronopharmacological effects of growth hormone on the executive function and oxidative stress response in rats |
| Q33936965 | Circulating insulin-like growth factor-1 and its binding protein-3: metabolic and genetic correlates in the community |
| Q38628608 | Combined sprint and resistance training abrogates age differences in somatotropic hormones. |
| Q36982007 | Complex rhythmicity and age dependence of growth hormone secretion are preserved in patients with acromegaly: further evidence for a present hypothalamic control of pituitary somatotropinomas |
| Q38108655 | Crosstalk between the circadian clock circuitry and the immune system. |
| Q37835640 | Current and potential roles of ghrelin in clinical practice |
| Q73500408 | DHEA-S levels in hypopituitaric patients with severe GH deficiency are strongly reduced across lifespan. Comparison with IGF-I levels before and during rhGH replacement |
| Q34307124 | Deficiency of insulin-like growth factor 1 reduces sensitivity to aging-associated cardiomyocyte dysfunction |
| Q34474751 | Deficiency of insulin-like growth factor 1 reduces vulnerability to chronic alcohol intake-induced cardiomyocyte mechanical dysfunction: role of AMPK |
| Q48686049 | Dehydroepiandrosterone administration reverses the inhibitory influence of aging on gonadotrophin-releasing hormone gene expression in the male and female rat brain |
| Q34311610 | Dehydroepiandrosterone sulfate and longevity: new clues for an old friend |
| Q34554963 | Dementia: a neuroendocrine perspective |
| Q37731946 | Diet and age interactions with regards to cholesterol regulation and brain pathogenesis |
| Q86630320 | Dietary restriction maintains the basal rate of somatotrope renewal in later life in male rats |
| Q36392385 | Diurnal secretion of growth hormone, cortisol, and dehydroepiandrosterone in pre- and perimenopausal women with active rheumatoid arthritis: a pilot case-control study |
| Q35947444 | Diverse roles of growth hormone and insulin-like growth factor-1 in mammalian aging: progress and controversies. |
| Q37466735 | Dyslipidemia in rat fed with high-fat diet is not associated with PCSK9-LDL-receptor pathway but ageing |
| Q42616453 | Effect of recombinant human growth hormone in elderly osteoporotic women |
| Q45151913 | Effect of recombinant human growth hormone on age-related hepatocyte changes in old male and female Wistar rats |
| Q33667282 | Effect of regular yogic training on growth hormone and dehydroepiandrosterone sulfate as an endocrine marker of aging |
| Q34080011 | Effects of 3-year GH replacement therapy on bone mineral density in younger and elderly adults with adult-onset GH deficiency. |
| Q47139969 | Effects of growth hormone administration on luteinizing hormone secretion in healthy older men and women |
| Q30483339 | Effects of short-term treadmill exercise training or growth hormone supplementation on diastolic function and exercise tolerance in old rats |
| Q37325147 | Endocrine alterations in response to calorie restriction in humans |
| Q44562987 | Endocrine alterations in the aging male |
| Q36894535 | Estrogens regulate the hepatic effects of growth hormone, a hormonal interplay with multiple fates |
| Q37077441 | Expression of lymphocyte-derived growth hormone (GH) and GH-releasing hormone receptors in aging rats |
| Q37150012 | Frailty, osteoporosis and hip fracture: causes, consequences and therapeutic perspectives. |
| Q49210474 | GH administration and discontinuation in healthy elderly men: effects on body composition, GH-related serum markers, resting heart rate and resting oxygen uptake. |
| Q35947436 | GH and IGF1: roles in energy metabolism of long-living GH mutant mice |
| Q39287747 | GH and ageing: Pitfalls and new insights |
| Q96303481 | Glucocorticoid Signaling and the Aging Heart |
| Q88658375 | Growth Hormone and Aging: Updated Review |
| Q52652594 | Growth hormone - past, present and future. |
| Q81462657 | Growth hormone abuse and bodybuilding as aetiological factors in the development of bilateral internal laryngocoeles. A case report |
| Q39577857 | Growth hormone administration and exercise effects on muscle fiber type and diameter in moderately frail older people |
| Q77092822 | Growth hormone and aging |
| Q86631569 | Growth hormone and aging |
| Q37366801 | Growth hormone and bile acid synthesis. Key role for the activity of hepatic microsomal cholesterol 7alpha-hydroxylase in the rat. |
| Q37379541 | Growth hormone and sex steroid effects on serum glucose, insulin, and lipid concentrations in healthy older women and men. |
| Q41375529 | Growth hormone cotreatment with gonadotropins in ovulation induction |
| Q73196666 | Growth hormone deficiency in elderly patients with hypothalamo-pituitary tumors |
| Q28572830 | Growth hormone rescues hippocampal synaptic function after sleep deprivation |
| Q52510028 | Growth hormone secretion after the administration of GHRP-6 or GHRH combined with GHRP-6 does not decline in late adulthood. |
| Q53510336 | Growth hormone signaling pathways. |
| Q36159113 | Growth hormone, inflammation and aging |
| Q34381507 | Growth hormone-releasing hormone combined with arginine or growth hormone secretagogues for the diagnosis of growth hormone deficiency in adults |
| Q34652032 | Growth hormone-releasing hormone effects on brain γ-aminobutyric acid levels in mild cognitive impairment and healthy aging. |
| Q47873128 | Growth hormone. A paracrine growth factor? |
| Q37321948 | Guidelines for the treatment of growth hormone excess and growth hormone deficiency in adults |
| Q58835295 | Healthy Aging Is Associated with Unaltered Production of Immunoreactive Growth Hormone but Impaired Neuroimmunomodulation |
| Q33569163 | Hormone replacement therapy and physical function in healthy older men. Time to talk hormones? |
| Q35694473 | Human growth hormone and the temptations of biomedical enhancement. |
| Q92495451 | Human growth hormone level decreased in women aged <60 years but increased in men aged >50 years |
| Q41693112 | IGFBP-3. Functional and structural implications in aging and wasting syndromes |
| Q33689066 | In case of obesity, longevity-related mechanisms lead to anti-inflammation |
| Q38921870 | Insulin growth factor-1 correlates with higher bone mineral density and lower inflammation status in obese adult subjects. |
| Q33873279 | Insulin-Like growth factor I: implications in aging |
| Q34652853 | Insulin-like growth factor 1 (IGF-1) enhances the protein expression of CFTR. |
| Q36772331 | Insulin-like growth factor 1 and musculoskeletal pain among breast cancer patients on aromatase inhibitor therapy and women without a history of cancer |
| Q35554024 | Insulin-like growth factor I gene promoter polymorphism, collagen type II alpha1 (COL2A1) gene, and the prevalence of radiographic osteoarthritis: the Rotterdam Study |
| Q36068042 | Insulin-like growth factor I levels and the diagnosis of adult growth hormone deficiency. |
| Q33936964 | Interaction between aging and syndrome X: new insights on the pathophysiology of fat distribution |
| Q78966897 | Interactions between serum leptin, the insulin-like growth factor-I system, and sex, age, anthropometric and body composition variables in a healthy population randomly selected |
| Q30307314 | Interactive regulation of postmenopausal growth hormone insulin-like growth factor axis by estrogen and growth hormone-releasing peptide-2. |
| Q35986830 | Interpretation of hormone levels in older patients: points for consideration |
| Q48686386 | Is the persistence of isolated GH deficiency in adulthood predicted by anatomical hypothalamic-pituitary alterations? |
| Q35747940 | Life span extension by reduction in growth hormone-insulin-like growth factor-1 axis in a transgenic rat model |
| Q34444314 | Managing the transition of adolescents with GH deficiency |
| Q48943336 | Memory performance and the growth hormone/insulin-like growth factor axis in elderly: a positron emission tomography study |
| Q36030348 | Meta-Analysis of Serum Insulin-Like Growth Factor 1 in Alzheimer's Disease |
| Q33806547 | Molecular and phenotypic biomarkers of aging |
| Q36641515 | Morphology of ovaries in laron dwarf mice, with low circulating plasma levels of insulin-like growth factor-1 (IGF-1), and in bovine GH-transgenic mice, with high circulating plasma levels of IGF-1 |
| Q58887077 | Paradoxical elevations in serum IGF-II and IGF binding protein-2 in acromegaly: insights into the regulation of these peptides |
| Q39241703 | Periplasmic production via the pET expression system of soluble, bioactive human growth hormone |
| Q36494366 | Pituitary and/or peripheral estrogen-receptor alpha regulates follicle-stimulating hormone secretion, whereas central estrogenic pathways direct growth hormone and prolactin secretion in postmenopausal women |
| Q33770506 | Pituitary physiological and ultrastructural changes during aging |
| Q37061417 | Potential biomarkers of ageing. |
| Q33944120 | Preclinical pharmacology of CP-424,391, an orally active pyrazolinone-piperidine [correction of pyrazolidinone-piperidine] growth hormone secretagogue |
| Q36795884 | Qualitative identification of growth hormone-releasing hormones in human plasma by means of immunoaffinity purification and LC-HRMS/MS. |
| Q28084341 | Quality control systems in cardiac aging |
| Q78766915 | Recombinant human growth hormone treatment in elderly patients undergoing elective total hip replacement |
| Q48558514 | Reduction of the somatotrope responsiveness to GHRH and Hexarelin but not to arginine plus GHRH in hyperprolactinemic patients |
| Q36873289 | Relationship among insulin resistance, growth hormone, and insulin-like growth factor I concentrations in diestrous Swedish Elkhounds. |
| Q37487986 | Relationship between changes in body fat and a decline of renal function in the elderly |
| Q47133991 | Role of Galectin-3 in Bone Cell Differentiation, Bone Pathophysiology and Vascular Osteogenesis. |
| Q52341096 | Role of IGF-I and Efn-Eph Signaling in Skeletal Metabolism. |
| Q41693094 | Role of IGF-I in muscular atrophy of aging |
| Q34995247 | Role of hormones in the pathogenesis and management of sarcopenia |
| Q41693091 | Sarcopenia and hormonal changes |
| Q38071216 | Secretion of microvesicular miRNAs in cellular and organismal aging. |
| Q33969145 | Sequence variations in the bovine growth hormone gene characterized by single-strand conformation polymorphism (SSCP) analysis and their association with milk production traits in Holsteins. |
| Q34698741 | Serum IGF-1 affects skeletal acquisition in a temporal and compartment-specific manner |
| Q33997381 | Serum levels of insulin-like growth factor (IGF); IGF-binding proteins-3, -4, and -5; and their relationships to bone mineral density and the risk of vertebral fractures in postmenopausal women |
| Q37195651 | Sex Differences in Age-Related Decline of Urinary Insulin-Like Growth Factor-Binding Protein-3 Levels in Adult Bonobos and Chimpanzees |
| Q61447847 | Short-term antidepressant treatment has long-lasting effects, and reverses stress-induced decreases in bone features in rats |
| Q26772966 | Significantly Higher Peripheral Insulin-Like Growth Factor-1 Levels in Patients With Major Depressive Disorder or Bipolar Disorder Than in Healthy Controls: A Meta-Analysis and Review Under Guideline of PRISMA |
| Q34433921 | Simultaneous stimulation of slow-wave sleep and growth hormone secretion by gamma-hydroxybutyrate in normal young Men. |
| Q39527508 | Skeletal effects of growth hormone and insulin-like growth factor-I therapy. |
| Q37158512 | Somatotropic signaling: trade-offs between growth, reproductive development, and longevity |
| Q33619640 | Stress and Alterations in Bones: An Interdisciplinary Perspective |
| Q40985287 | Studies of Growth Hormone/Insulin‐like, Growth Factor‐I in Polio Survivorsa |
| Q50998584 | Superoxide anion release from neutrophils in growth hormone deficient adults before and after replacement therapy with recombinant human growth hormone. |
| Q30447872 | Testosterone and estradiol regulate free insulin-like growth factor I (IGF-I), IGF binding protein 1 (IGFBP-1), and dimeric IGF-I/IGFBP-1 concentrations |
| Q37212304 | Testosterone and growth hormone improve body composition and muscle performance in older men. |
| Q36686910 | Testosterone improves the regeneration of old and young mouse skeletal muscle |
| Q34545977 | Testosterone threshold levels and lean tissue mass targets needed to enhance skeletal muscle strength and function: the HORMA trial |
| Q38578328 | The Aging Heart |
| Q33654009 | The GH/IGF-1 Axis and Heart Failure |
| Q38731472 | The Link Between Inadequate Sleep and Obesity in Young Adults |
| Q33596295 | The effect of caloric restriction interventions on growth hormone secretion in nonobese men and women |
| Q44622913 | The effect of recombinant human growth hormone and resistance training on IGF-I mRNA expression in the muscles of elderly men. |
| Q40978240 | The effects of exercise on growth |
| Q34150795 | The effects of growth hormone and IGF-1 deficiency on cerebrovascular and brain ageing |
| Q35067036 | The effects of long-term resistance exercise on the relationship between neurocognitive performance and GH, IGF-1, and homocysteine levels in the elderly. |
| Q37975168 | The hormonal pathway to cognitive impairment in older men. |
| Q37148756 | The influence of estrogens on the biological and therapeutic actions of growth hormone in the liver |
| Q37349999 | The influence of sleep and sleep loss upon food intake and metabolism |
| Q73769046 | The negative GH auto-feedback in childhood: effects of rhGH and/or GHRH on the somatotroph response to GHRH or hexarelin, a peptidyl GH secretagogue, in children |
| Q35335129 | The response of muscle protein anabolism to combined hyperaminoacidemia and glucose-induced hyperinsulinemia is impaired in the elderly. |
| Q41657129 | Therapeutic options for HIV-associated bodyweight loss. A risk-benefit analysis |
| Q44435854 | Three-hour spontaneous GH secretion profile is as reliable as oral glucose tolerance test for the diagnosis of acromegaly |
| Q33361660 | Transcriptome-wide assessment of human brain and lymphocyte senescence. |
| Q37121707 | Transitioning of children with GH deficiency to adult dosing: changes in body composition |
| Q36789726 | Treatment of post-menopausal osteoporosis with a combination of growth hormone and pamidronate: a placebo controlled trial |
| Q77511271 | Usefulness of IGF-I assay for the diagnosis of GH deficiency in adults |
| Q36601648 | Vesicular Galectin-3 levels decrease with donor age and contribute to the reduced osteo-inductive potential of human plasma derived extracellular vesicles |
| Q30318375 | Vessel aging. The role of oxidative stress and protein glycation |
| Q34088290 | Vibration as an exercise modality: how it may work, and what its potential might be. |
| Q35850965 | Vitamin D safety and requirements |
| Q51097778 | Wishing a dream came true: DHEA as a rejuvenating treatment? |
| Q84245432 | [Dermatoendocrinology. Skin aging] |
| Q84867350 | [Skin aging] |
Search more.